Our previous study had confirmed that lentivirus-mediated RNAi silencing targeting ABCC2 might reverse the ABCC2-related drug resistance of NPC cell line CNE2 against CDDP [10]. The gene discussed is ABCC2; the disease is nasopharyngeal carcinoma.